Nexgenrx Inc (NXG.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 833 | 317 | 130 | 75 | 74 |
| Income taxes - deferred | -83 | -34 | 0 | -175 | N/A |
| Accounts receivable | 278 | -475 | 12 | -27 | 53 |
| Accounts payable and accrued liabilities | 67 | 193 | N/A | N/A | N/A |
| Other Working Capital | 266 | -239 | 224 | 5 | 297 |
| Other Operating Activity | -316 | -270 | -625 | 613 | -459 |
| Operating Cash Flow | $1,046 | $-507 | $-259 | $491 | $-35 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | -34 | -38 | -51 | -42 |
| Purchase Sale Intangibles | -906 | -369 | N/A | N/A | -62 |
| Other Investing Activity | 0 | 0 | -424 | -304 | 0 |
| Investing Cash Flow | $-957 | $-403 | $-463 | $-355 | $-104 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 0 | -390 |
| Debt Issued | 1,325 | 1,750 | 360 | 0 | N/A |
| Debt Repayment | -1,720 | -132 | -78 | -19 | N/A |
| Common Stock Issued | 0 | 425 | 1,796 | 240 | 550 |
| Other Financing Activity | 0 | -2,325 | -10 | 0 | 0 |
| Financing Cash Flow | $-395 | $-283 | $2,067 | $221 | $160 |
| Beginning Cash Position | 834 | 2,027 | 681 | 324 | 303 |
| End Cash Position | 527 | 834 | 2,027 | 681 | 324 |
| Net Cash Flow | $-307 | $-1,193 | $1,346 | $357 | $21 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,046 | -507 | -259 | 491 | -35 |
| Capital Expenditure | -957 | -403 | -463 | -355 | -104 |
| Free Cash Flow | 89 | -911 | -722 | 136 | -139 |